Status:
COMPLETED
Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation
Lead Sponsor:
Innovative Medical
Conditions:
Macula Thickening
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.
Eligibility Criteria
Inclusion
- Males or females \> 50 years old
- Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL.
- Likely to complete all study visits and able to provide informed consent
- Visual potential of 20/25 or better
Exclusion
- · Prior use of topical ketorolac
- Known contraindications to any study medication or ingredients
- Active ocular diseases or uncontrolled systemic disease
- Active ocular allergies
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00433225
Last Update
September 10 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Consultants of Long Island
Rockville Centre, New York, United States, 11570